| 1 | 7532153 | Production of mouse monoclonal anti-idiotypic antibodies specific to epitopes of tumor-associated mucin TAG-12. | Hybridoma | 1994 Oct |
1 |
| 2 | 8325651 | Cloning and characterization of the cDNA for the murine iduronate sulfatase gene. | Genomics | 1993 Jun |
4 |
| 3 | 15149955 | Identification of iduronate-2-sulfatase in mouse pancreatic islets. | Am J Physiol Endocrinol Metab | 2004 Nov |
4 |
| 4 | 15368360 | Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo. | J Cell Biochem | 2004 Oct 1 |
1 |
| 5 | 15966019 | Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts. | J Gene Med | 2005 Nov |
7 |
| 6 | 17459751 | Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II. | Mol Genet Metab | 2007 Jun |
10 |
| 7 | 20876612 | Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy. | Hum Mol Genet | 2010 Dec 15 |
2 |
| 8 | 21319344 | Changes in glycogen and glycosaminoglycan levels in hepatocytes of iduronate-2-sulfatase knockout mice before and after recombinant iduronate-2-sulfatase supplementation. | Yonsei Med J | 2011 Mar |
2 |
| 9 | 22019851 | Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressors. | Biochem Biophys Res Commun | 2011 Nov 4 |
1 |
| 10 | 22279584 | CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder. | PLoS One | 2012 |
1 |
| 11 | 22704483 | Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. | Mol Genet Metab | 2012 Sep |
1 |
| 12 | 23529876 | Improvement of CNS defects via continuous intrathecal enzyme replacement by osmotic pump in mucopolysaccharidosis type II mice. | Am J Med Genet A | 2013 May |
2 |
| 13 | 24005894 | High-dose enzyme replacement therapy attenuates cerebroventriculomegaly in a mouse model of mucopolysaccharidosis type II. | J Hum Genet | 2013 Nov |
1 |
| 14 | 25761450 | Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II. | Hum Gene Ther | 2015 Jun |
1 |
| 15 | 27510804 | Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II Mice. | Hum Gene Ther | 2016 Nov |
2 |
| 16 | 27699273 | CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome). | JCI Insight | 2016 Jun 16 |
6 |
| 17 | 27873002 | Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry. | Anal Bioanal Chem | 2017 Feb |
3 |
| 18 | 28207863 | Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II. | PLoS One | 2017 |
4 |
| 19 | 28478695 | Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer. | Hum Gene Ther | 2017 Aug |
3 |
| 20 | 29606503 | A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II. | Mol Ther | 2018 May 2 |
2 |
| 21 | 29978271 | The efficacy of intracerebroventricular idursulfase-beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology. | J Inherit Metab Dis | 2018 Nov |
4 |
| 22 | 30064964 | Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS. | Mol Genet Metab | 2018 Sep |
5 |
| 23 | 31193135 | Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain. | Heliyon | 2019 May |
10 |
| 24 | 32623553 | Evidence for inflammasome activation in the brain of mucopolysaccharidosis type II mice. | Metab Brain Dis | 2020 Oct |
4 |
| 25 | 32631737 | Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy. | Mol Genet Metab | 2020 Aug |
1 |
| 26 | 32751752 | High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II. | Int J Mol Sci | 2020 Jul 30 |
2 |
| 27 | 34622797 | Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome. | JCI Insight | 2021 Oct 8 |
2 |
| 28 | 35284671 | Iduronate-2-sulfatase interactome: validation by yeast two-hybrid assay. | Heliyon | 2022 Mar |
6 |